Adam is a world-renowned researcher in the area of high-throughput biological assays. Companies founded on the basis of his groundbreaking microfluidics discoveries include GnuBIO, Mission Bio, Scribe, and Fluent BioSciences. Currently a physicist with the University of California, San Francisco, Adam holds an appointment there as an associate professor of bioengineering and therapeutic sciences. More than 20 patents bear his name, as do 100 published studies. Additionally, Adam serves as an investigator for the Chan Zuckerberg Biohub and California Institute for Quantitative Biosciences.
Adam received a AB degree from Harvard University and a PhD from the University of Pennsylvania; he completed postdoctoral work at Harvard.